Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.16 - $0.34 $1,424 - $3,026
8,900 Added 3.26%
282,187 $44,000
Q2 2023

Aug 11, 2023

BUY
$0.24 - $0.37 $960 - $1,480
4,000 Added 1.49%
273,287 $71,000
Q1 2023

May 12, 2023

SELL
$0.32 - $0.68 $93,252 - $198,160
-291,413 Reduced 51.97%
269,287 $86,000
Q4 2022

Feb 13, 2023

SELL
$0.35 - $1.26 $41,510 - $149,436
-118,600 Reduced 17.46%
560,700 $235,000
Q3 2022

Nov 14, 2022

BUY
$1.12 - $3.12 $164,765 - $458,989
147,112 Added 27.64%
679,300 $661,000
Q2 2022

Aug 12, 2022

BUY
$2.76 - $7.65 $287,006 - $795,508
103,988 Added 24.28%
532,188 $1.55 Million
Q1 2022

May 13, 2022

BUY
$5.63 - $13.88 $1.43 Million - $3.53 Million
254,600 Added 146.66%
428,200 $3.22 Million
Q4 2021

Feb 11, 2022

BUY
$13.23 - $26.05 $1.87 Million - $3.68 Million
141,100 Added 434.15%
173,600 $2.43 Million
Q3 2021

Nov 12, 2021

BUY
$25.87 - $46.61 $840,775 - $1.51 Million
32,500 New
32,500 $841,000

Others Institutions Holding AMTI

# of Institutions
1
Shares Held
9.42K
Call Options Held
0
Put Options Held
0

About Applied Molecular Transport Inc.


  • Ticker AMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,900,600
  • Description
  • Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...
More about AMTI
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.